
Cytokinetics grants stock options and RSUs to new employees as inducements under Nasdaq rules.
Cytokinetics granted stock options for 20,807 shares and 13,793 restricted stock units (RSUs) to eight new employees who started in April and May 2026. The RSUs vest over three years, while the stock options vest over four years with an exercise pric...

